Stephens Investment Management Group LLC Reduces Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Stephens Investment Management Group LLC lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 179,537 shares of the company’s stock after selling 179 shares during the period. Stephens Investment Management Group LLC owned 0.14% of Henry Schein worth $12,424,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. Cromwell Holdings LLC increased its position in Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the last quarter. Studio Investment Management LLC raised its stake in Henry Schein by 3.8% in the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after acquiring an additional 172 shares during the period. Central Pacific Bank Trust Division lifted its holdings in Henry Schein by 2.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after purchasing an additional 200 shares during the last quarter. Huntington National Bank boosted its position in Henry Schein by 16.8% during the third quarter. Huntington National Bank now owns 1,515 shares of the company’s stock worth $110,000 after purchasing an additional 218 shares during the period. Finally, Bridge Creek Capital Management LLC boosted its position in Henry Schein by 0.7% during the fourth quarter. Bridge Creek Capital Management LLC now owns 38,763 shares of the company’s stock worth $2,682,000 after purchasing an additional 260 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 1.1 %

Shares of NASDAQ:HSIC opened at $79.00 on Monday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a fifty day moving average of $73.70 and a 200 day moving average of $71.80. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The firm has a market capitalization of $9.85 billion, a PE ratio of 32.51, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HSIC. Jefferies Financial Group upped their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho began coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. Barrington Research raised their target price on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Seven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $80.10.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.